Nabilah Razak
Boston Scientific trims outlook again
Boston Scientific trims 2026 sales and earnings guidance due to slowing growth in key product lines, including Watchman and electrophysiology, affecting its…
Abbott Launches Study Amid Crowded Heart Valve Market
Abbott launches a comprehensive heart valve study assessing its TriClip device's real-world safety and performance in treating tricuspid valves.
User Blocked After Policy Violation
Ravulizumab trial results reveal no significant improvement in event‑free survival for HSCT‑TMA patients, highlighting challenges in this rare transplant compli
Sorry, you have been blocked
Flu vaccination rates in the US have dropped to 43.8% for adults and children. Learn why coverage is down and the public…
User access denied after system block
Treating blood cancer in prisons requires specialized care and planning to overcome unique challenges for inmates. Learn effective strategies.
Apology as user is blocked
Explore growing options for second-line therapy as clinicians tailor treatments to patient needs and preferences.
User access denied after block
Hospital financial assistance documents often exceed the reading level of most Americans, leaving critical aid inaccessible. Learn why readability matters.